내강 봉합 디바이스 시장 : 제품 유형, 모달리티, 소재 유형, 용도, 최종 사용자, 유통 채널별 예측(2026-2032년)

The Endoluminal Suturing Devices Market is projected to grow by USD 130.90 billion at a CAGR of 13.26% by 2032.

Endoluminal Suturing Devices Market Introduction

The endoluminal suturing devices market is positioned at the intersection of therapeutic endoscopy, minimally invasive gastrointestinal care, bariatric intervention, and advanced defect closure. These devices enable physicians to place full-thickness or deep-tissue sutures through flexible endoscopes, supporting procedures such as endoscopic sleeve gastroplasty, closure of perforations, fistulas and leaks, stent fixation, and post-resection defect management.

Demand is supported by verifiable healthcare trends: the World Health Organization reports that more than 1 billion people were living with obesity in 2022, and colorectal cancer remains among the most commonly diagnosed cancers worldwide, according to global cancer surveillance data. These realities increase the clinical relevance of less invasive GI interventions that can reduce open or laparoscopic surgical burden, shorten recovery pathways, and expand treatment options for complex patients.

Transformative Shifts in the Endoluminal Suturing Landscape

The market landscape is shifting from diagnostic endoscopy toward advanced therapeutic endoscopy. Hospitals and ambulatory endoscopy centers are increasingly evaluating endoscopic suturing systems as part of broader minimally invasive surgery strategies, especially where defect closure, bariatric endoscopy, and revision procedures can be performed without external incisions.

A second transformation is the movement toward integrated platforms. Device developers are focusing on improved tissue acquisition, ergonomic controls, compatibility with widely used endoscopes, and training models that reduce the learning curve. Adoption is also shaped by reimbursement clarity, clinical guideline evolution, credentialing requirements, and institutional investment in advanced endoscopy programs.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is not replacing endoscopic suturing, but it is reshaping the surrounding clinical workflow. FDA-authorized AI-assisted endoscopy tools, including computer-aided detection systems for colonoscopy, have demonstrated how real-time image analysis can support GI decision-making and standardization. This creates a pathway for AI-enabled procedure planning, lesion characterization, documentation, and training analytics in therapeutic endoscopy.

For endoluminal suturing devices, the cumulative impact of AI is strongest in pre-procedure assessment, case selection, navigation support, quality benchmarking, and post-procedure surveillance. Manufacturers that connect suturing platforms with digital procedure data, simulation, and outcomes tracking will be better positioned as hospitals prioritize measurable clinical value, workflow consistency, and quality reporting.

Key Regional Insights for Endoluminal Suturing Devices

Asia-Pacific is gaining strategic importance due to large patient populations, expanding endoscopy infrastructure, and rising demand for minimally invasive GI treatment across China, India, Japan, South Korea, Australia, and ASEAN markets. Adoption varies widely, with Japan and South Korea supported by sophisticated endoscopy ecosystems and high procedural expertise, while India and China offer scale but require cost-sensitive access models, physician training, and broader distribution support.

North America remains a leading adoption region due to established advanced endoscopy programs, FDA-regulated device pathways, high obesity prevalence, colorectal cancer screening infrastructure, and strong demand for complex GI defect management. Europe benefits from university hospital networks, structured clinical evaluation, and specialist societies, though procurement, health technology assessment, and reimbursement differ by country. Latin America, the Middle East, and Africa are emerging adoption areas where private hospital investment, medical tourism, tertiary-care expansion, obesity-related care demand, and specialist training will influence the pace of endoluminal suturing device utilization.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

Within ASEAN, demand is supported by expanding private healthcare systems and growing endoscopy capabilities in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines, though affordability, referral networks, and specialist availability remain decisive. The GCC shows strong potential through tertiary hospitals, obesity-related care demand, government healthcare modernization programs, and investments in premium minimally invasive technologies.

The European Union provides a significant evidence-driven environment where clinical outcomes, health technology assessment, medical device regulation, and procurement transparency shape adoption. BRICS countries combine large disease burden with uneven access, making tiered pricing, physician training, local clinical evidence, and distribution partnerships important. G7 markets generally lead in regulatory maturity, clinical research capacity, and early technology adoption, while NATO member countries overlap substantially with advanced hospital systems that prioritize resilient medtech supply chains, procedure standardization, and consistent quality of care.

Key Country Insights for Priority Markets

The United States is central to commercial strategy because of its advanced endoscopy centers, high obesity prevalence, colorectal disease burden, and mature FDA-cleared medical device environment. Canada offers stable adoption through specialist hospitals and publicly structured healthcare evaluation, while Mexico and Brazil are important Latin American markets where private-sector investment, medical tourism, and bariatric care demand support procedural expansion.

In Europe, the United Kingdom, Germany, France, Italy, and Spain anchor demand through tertiary hospitals, established GI societies, colorectal cancer programs, and advanced therapeutic endoscopy expertise, while Russia presents access, regulatory, and supply-chain complexity. In Asia-Pacific, China and India offer major long-term scale through large patient pools and expanding hospital infrastructure, Japan and South Korea provide advanced procedural expertise and strong endoscopy adoption, and Australia supports utilization through high-quality specialist care, regulated technology assessment, and structured clinical governance.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinical evidence generation, particularly comparative studies that evaluate technical success, safety, durability of closure, adverse event profiles, procedure time, learning curve, and long-term outcomes in bariatric and defect-closure indications. Evidence that aligns with payer expectations, clinical guideline development, and hospital value-analysis committees will improve adoption.

Companies should also invest in structured physician training, proctorship, simulation, and digital education. Commercial teams should segment customers by procedural maturity, create region-specific access models, strengthen post-market surveillance, and build partnerships with advanced endoscopy societies, bariatric centers, colorectal programs, and tertiary referral hospitals.

Research Methodology

This executive summary is developed through secondary research using publicly available, verifiable sources, including regulatory agency databases, clinical society publications, peer-reviewed medical literature, hospital technology adoption patterns, and global health data from organizations such as WHO, international cancer surveillance resources, and national health authorities.

The methodology emphasizes triangulation across clinical, regulatory, epidemiological, and commercial indicators. Insights are interpreted through market intelligence lens to reflect demand drivers, adoption barriers, regional dynamics, technology shifts, and procedural priorities relevant to endoluminal suturing devices, without applying market sizing, market share, or forecasting assumptions.

Conclusion

The endoluminal suturing devices market is moving from niche advanced endoscopy toward broader clinical relevance as minimally invasive GI care expands. Obesity, colorectal disease, complex defect closure, bariatric revision, and demand for organ-sparing procedures continue to reinforce the need for flexible endoscopic suturing technologies.

Future competitiveness will depend on clinical evidence, ease of use, training infrastructure, reimbursement progress, regulatory compliance, and integration with digital endoscopy workflows. Organizations that combine device innovation with measurable outcomes, scalable education, and reliable access models will be best positioned for sustainable growth.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Endoluminal Suturing Devices Market, by Product Type

• 7.1. Endoluminal Suturing Devices
• 7.2. Accessories
  • 7.2.1. Sutures
  • 7.2.2. Needles
  • 7.2.3. Anchors
  • 7.2.4. Tissue Graspers

8. Endoluminal Suturing Devices Market, by Modality

• 8.1. Disposable Devices
• 8.2. Reusable Devices

9. Endoluminal Suturing Devices Market, by Material Type

• 9.1. Synthetic Materials
  • 9.1.1. Polypropylene-Based Sutures
  • 9.1.2. Nylon-Based Sutures
• 9.2. Bioabsorbable Materials
  • 9.2.1. Polyglycolic Acid (PGA)
  • 9.2.2. Polylactic Acid (PLA)
  • 9.2.3. Polydioxanone (PDO)

10. Endoluminal Suturing Devices Market, by Application

• 10.1. Gastrointestinal
  • 10.1.1. Gastric Defect Closure
  • 10.1.2. Enterotomy Closure
  • 10.1.3. Perforation Repair
• 10.2. Bariatric Surgery
  • 10.2.1. Sleeve Gastrectomy Suturing
  • 10.2.2. Gastric Bypass Suturing
  • 10.2.3. Stoma Reduction
• 10.3. Colorectal
• 10.4. Esophageal
• 10.5. Hepatobiliary
• 10.6. Urological

11. Endoluminal Suturing Devices Market, by End User

• 11.1. Ambulatory Surgical Centers
• 11.2. Hospitals
• 11.3. Specialty Clinics

12. Endoluminal Suturing Devices Market, by Distribution Channel

• 12.1. Online
• 12.2. Offline

13. Endoluminal Suturing Devices Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Endoluminal Suturing Devices Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Endoluminal Suturing Devices Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Boston Scientific Corporation
• 17.2. Cook Group Incorporated
• 17.3. Endo Tools Therapeutics S.A.
• 17.4. ErgoSuture
• 17.5. Ethicon, Inc.
• 17.6. Fujifilm Holdings Corporation
• 17.7. Karl Storz SE & Co. KG
• 17.8. Medtronic plc
• 17.9. Olympus Corporation
• 17.10. Ovesco Endoscopy AG
• 17.11. PENTAX Medical
• 17.12. Richard Wolf GmbH
• 17.13. USGI Medical, Inc.